// App-Quantinova.ai

2368 : Impact of Physician- Adherence to Treat-to-Target Strategy on Outcomes in Early Rheumatoid Arthritis

Researchers

Presenter

  • Laura Kuusalo

Principal Investigators

  • Kari Puolakka

  • Hannu Kautiainen

  • Marjatta Leirisalo-Repo

  • Vappu Rantalaiho

Medical Centers

  • Department of Internal Medicine, South Karelia Central Hospital, Lappeenranta, Finland

  • Department of Internal Medicine, Center for Rheumatic Diseases, Tampere University Hospital, Tampere, Finland

  • Department of Medicine, Division of Rheumatology, Helsinki University Central Hospital, Helsinki, Finland

  • Medcare Oy, Aanekoski, Finland

  • Internal Medicine, Division of Rheumatology, Turku University Central Hospital, Turku, Finland

Locations

  • Finland

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • Estrogen receptor alpha

Drug/Treatment

  • Hydroxychloroquine

  • Glucocorticoid

  • Sulfasalazine

  • Methotrexate

  • Prednisolone

  • Infliximab

Outcome

  • N/A

Study Design

  • randomized

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved